drugset / Trial / NCT00046761

A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

NCT00046761 ↗

Phase 2/3 Terminated 1320 enrolled Ono Pharma USA Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.

Timeline

Start
2002-11
Primary completion
2005-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject ARUNDIC ACID Small molecule — Intravenous

Indications